Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study

Fegrachi Samira; Walma Marieke S.; de Vries Jan J. J.; van Santvoort Hjalmar C.; Besselink Marc G.; von Asmuth Erik G.; van Leeuwen Maarten S.; Rinkes Inne H. Borel; Bruijnen Rutger C.; de Hingh Ignace H.; Klaase Joost M.; Molenaar I. Quintus; van Hillegersberg Richard

首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study

【24h】

Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study

机译：局部先进，不可切征胰腺癌患者射频消融的安全性：II期研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Radiofrequency ablation (RFA) has been proposed as a new treatment option for locally advanced, unresectable pancreatic cancer (LAPC). In preparation of a randomized controlled trial (RCT), the aim of this phase II study was to assess the safety of RFA for patients with LAPC.

机译：简介：射频消融（RFA）已提出作为局部晚期，不可切征的胰腺癌（LAPC）的新治疗选择。在制备随机对照试验（RCT）时，本II期研究的目的是评估RFA对LAPC患者的安全性。

著录项

来源
《European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 》 |2019年第11期| 共7页
作者
Fegrachi Samira; Walma Marieke S.; de Vries Jan J. J.; van Santvoort Hjalmar C.; Besselink Marc G.; von Asmuth Erik G.; van Leeuwen Maarten S.; Rinkes Inne H. Borel; Bruijnen Rutger C.; de Hingh Ignace H.; Klaase Joost M.; Molenaar I. Quintus; van Hillegersberg Richard;
展开▼
作者单位

Univ Med Ctr Utrecht St Antonius Hosp Nieuwegein Reg Acad Canc Ctr Utrecht Dept Surg Canc Ctr;

Univ Med Ctr Utrecht St Antonius Hosp Nieuwegein Reg Acad Canc Ctr Utrecht Dept Surg Canc Ctr;

Vrije Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Radiol De Boelelaan 1117 NL-1081 HV;

Univ Med Ctr Utrecht St Antonius Hosp Nieuwegein Reg Acad Canc Ctr Utrecht Dept Surg Canc Ctr;

Univ Amsterdam Amsterdam UMC Canc Ctr Amsterdam Dept Surg Meibergdreef 9 NL-1100 DD Amsterdam;

Univ Med Ctr Utrecht St Antonius Hosp Nieuwegein Reg Acad Canc Ctr Utrecht Dept Surg Canc Ctr;

Univ Utrecht Canc Ctr Univ Med Ctr Utrecht Dept Radiol POB 85500 NL-3508 GA Utrecht;

Univ Med Ctr Utrecht St Antonius Hosp Nieuwegein Reg Acad Canc Ctr Utrecht Dept Surg Canc Ctr;

Univ Utrecht Canc Ctr Univ Med Ctr Utrecht Dept Radiol POB 85500 NL-3508 GA Utrecht;

Catharina Hosp Dept Surg Michelangelolaan 2 NL-5623 EJ Eindhoven Netherlands;

Univ Med Ctr Groningen Dept Surg Hanzepl 1 NL-9713 GZ Groningen Netherlands;

Univ Med Ctr Utrecht St Antonius Hosp Nieuwegein Reg Acad Canc Ctr Utrecht Dept Surg Canc Ctr;

Univ Med Ctr Utrecht St Antonius Hosp Nieuwegein Reg Acad Canc Ctr Utrecht Dept Surg Canc Ctr;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词
Locally advanced pancreatic cancer; Radiofrequency ablation; Phase II safety study;

机译：局部晚期的胰腺癌;射频消融;第II期安全研究;

相似文献

外文文献
中文文献
专利

1. Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study [J] . Fegrachi Samira, Walma Marieke S., de Vries Jan J. J., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2019 ,第11期

机译：局部先进，不可切征胰腺癌患者射频消融的安全性：II期研究
2. Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer [J] . Michele Fiore, Sara Ramella, Sergio Valeri, Scientific reports. . 2017 ,第1期

机译：II期诱导化疗的研究随后进行临界患者的化学疗法，局部晚期胰腺癌
3. Phase II study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. [J] . Sudo K, Yamaguchi T, Ishihara T, International Journal of Radiation Oncology, Biology, Physics . 2011 ,第1期

机译：不可切除的局部晚期胰腺癌患者口服S-1和同时放疗的II期研究。
4. Photodynamic therapy of locally advanced pancreatic cancer (VERTPAC study): final clinical results [C] . Huggett MT, Jermyn M, Gillams A, Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXII . 2013

机译：局部晚期胰腺癌的光动力疗法（VERTPAC研究）：最终临床结果
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer [O] . Michele Fiore, Sara Ramella, Sergio Valeri, -1

机译：边缘性可切除和不可切除的局部晚期胰腺癌患者的诱导化疗后放化疗的II期研究
7. Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results [O] . Mirko D’Onofrio, Stefano Crosara, Riccardo De Robertis, 2016

机译：经皮射频消融不可切除的局部晚期胰腺癌：初步结果

Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study

摘要

著录项

相似文献

相关主题

期刊订阅